Key Record Dates
ClinicalTrials.gov Identifier: | NCT03751007 |
---|---|
Brief Title: | A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D) |
First Submitted : | November 8, 2018 |
First Submitted that Met QC Criteria : | November 20, 2018 |
First Posted : | November 23, 2018 |
Last Update Submitted that Met QC Criteria : | February 9, 2021 |
Last Update Posted : | February 11, 2021 |